News

  • Werner Hemmert, Professor of Bio-inspired Information Processing at TUM

    3D computer models improve cochlear implant design

    07 October 2019 | A team of researchers led by MSB-PI Werner Hemmert have applied the latest computer modelling techniques to create better cochlear implants (CIs).

  • Abraham Lopez, Matthias Feige, Michael Sattler,  and Sina Bohnacker (from left).  Image: A. Heddergott / TUM

    Quality control in immune communication

    26 September 2019 | Cellular control proteins, referred to as chaperones, detect immature immune signaling proteins and prevent them from leaving the cell.

  • The summer school participants in the BrainLab auditorium

    Living out interdisciplinary science

    The Graduate School of BioEngineering (GSB) summer school brings together doctoral candidates from various departments at the Technical University of Munich (TUM). The scientists work in the fields of medical physics, medical informatics and robotics.

  • Michael Sattler at the BNMRZ.

    How proteins work – Article in TUM’s science magazine

    09 September 2019 | Faszination Forschung – the science magazine of the Technical University of Munich (TUM) – reported on the work at the Bavarian NMR Center (BNMRZ) at TUM. 

  • MSB-PI Vasilis Ntziachristos

    Radio feature about optoacoustic tomography (in German)

    04 September 2019 | German public radio (Deutschlandfunk) reported on the work of MSB-PI Vasilis Ntziachristos and his colleagues at the TUM professorship of Biological Imaging and the Institute for Biological and Medical Imaging at the Helmholtz Zentrum München.

  • Mechanism of new small molecule inhibitors for the treatment of depression, pain and obesity decoded

    27 August 2019 | Researchers at TUM and the Helmholtz Zentrum München have moved a step closer towards developing innovative drug molecules for the treatment of psychiatric diseases. They discovered how inhibitors inactivate a special protein that plays a key role in various diseases. Their approach can be applied to other medically relevant proteins where the development of specific inhibitors has proved difficult up to now. The research effort was led by Michael Sattler, Director of the Institute of Structural Biology at the Helmholtz Zentrum München and Professor of Biomolecular NMR-Spectroscopy at TUM as well as Principal Investigator at the MSB.